New NAPSIN1 Antibody Launched by Novus Biologicals

Novus Biologicals is excited to announce the release of a new NAPSIN1 Antibody (NB110-68133) for Napsin research.

Napsin1 (NAPSA) is a peptidase A1 protein that is thought to be involved in pneumocyte surfactant precursor processing. Napsin-1 is most strongly expressed in lung type II pneumocytes and kidney cells, and may be detected at low levels in adult spleen and peripheral blood leukocytes.

The Napsin 1 antibody (NB110-68133) may be used in WB and IHC on paraffin embedded human tissue samples.

Novus Biologicals also provides a broad catalog of other cellular markers. All Novus products are 100% guaranteed to work in the species and applications listed on the datasheet, and the Innovator's Reward Program supports testing in novel species and applications.